$POLA
Polar Power, Inc. Stock $pola

$pola Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224019861 Filed on May 15, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$1.775M	$4.190M
YoY Change	-57.64%	12.97%
Cost Of Revenue	$2.177M	$3.435M
YoY Change	-36.62%	22.5%
Gross Profit	-$402.0K	$755.0K
YoY Change	-153.25%	-16.57%
Gross Profit Margin	-22.65%	18.02%
Selling, General & Admin	$1.357M	$1.444M
YoY Change	-6.02%	-5.99%
% of Gross Profit		191.26%
Research & Development	$220.0K	$346.0K
YoY Change	-36.42%	-27.31%
% of Gross Profit		45.83%
Depreciation & Amortization	$66.00K	$116.0K
YoY Change	-43.1%	-14.07%
% of Gross Profit		15.36%
Operating Expenses	$1.577M	$1.790M
YoY Change	-11.9%	-11.03%
Operating Profit	-$1.979M	-$1.035M
YoY Change	91.21%	-6.5%
Interest Expense	$163.0K	$78.00K
YoY Change	108.97%	-700.0%
% of Operating Profit
Other Income/Expense, Net	-$163.0K	-$78.00K
YoY Change	108.97%
Pretax Income	-$2.142M	-$1.113M
YoY Change	92.45%	-0.63%
Income Tax
% Of Pretax Income
Net Earnings	-$2.142M	-$1.113M
YoY Change	92.45%	-0.63%
Net Earnings / Revenue	-120.68%	-26.56%
Basic Earnings Per Share	-$0.12	-$0.09
Diluted Earnings Per Share	-$0.12	-$0.09
COMMON SHARES
Basic Shares Outstanding	17.56M shares	12.95M shares
Diluted Shares Outstanding	17.56M shares	12.95M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$212.0K	$119.0K
YoY Change	78.15%	-97.16%
Cash & Equivalents	$212.0K	$119.0K
Short-Term Investments
Other Short-Term Assets	$2.444M	$3.852M
YoY Change	-36.55%	-26.82%
Inventory	$16.22M	$16.88M
Prepaid Expenses	$444.0K	$1.852M
Receivables	$1.282M	$3.216M
Other Receivables	$787.0K	$787.0K
Total Short-Term Assets	$20.95M	$24.85M
YoY Change	-15.71%	2.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$278.0K	$421.0K
YoY Change	-33.97%	-74.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$108.0K	$93.00K
YoY Change	16.13%	0.0%
Total Long-Term Assets	$2.916M	$2.950M
YoY Change	-1.15%	70.13%
TOTAL ASSETS
Total Short-Term Assets	$20.95M	$24.85M
Total Long-Term Assets	$2.916M	$2.950M
Total Assets	$23.86M	$27.80M
YoY Change	-14.16%	6.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.194M	$1.024M
YoY Change	16.6%	88.24%
Accrued Expenses	$2.328M	$1.994M
YoY Change	16.75%	4.84%
Deferred Revenue
YoY Change
Short-Term Debt	$4.914M	$3.010M
YoY Change	63.26%
Long-Term Debt Due	$297.0K	$172.0K
YoY Change	72.67%	-29.8%
Total Short-Term Liabilities	$11.28M	$8.969M
YoY Change	25.74%	148.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$33.00K
YoY Change	-100.0%	-83.9%
Other Long-Term Liabilities	$1.537M	$1.729M
YoY Change	-11.1%	1305.69%
Total Long-Term Liabilities	$1.537M	$1.762M
YoY Change	-12.77%	437.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.28M	$8.969M
Total Long-Term Liabilities	$1.537M	$1.762M
Total Liabilities	$12.82M	$10.73M
YoY Change	19.42%	172.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.80M	-$20.22M
YoY Change	37.47%
Common Stock	$2.000K	$1.000K
YoY Change	100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.05M	$17.07M
YoY Change
Total Liabilities & Shareholders Equity	$23.86M	$27.80M
YoY Change	-14.16%	6.62%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$2.142M	-$1.113M
YoY Change	92.45%	-0.63%
Depreciation, Depletion And Amortization	$66.00K	$116.0K
YoY Change	-43.1%	-14.07%
Cash From Operating Activities	-$989.0K	-$1.156M
YoY Change	-14.45%	36.48%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$652.0K	$1.064M
YoY Change	-38.72%	-1873.33%
NET CHANGE
Cash From Operating Activities	-$989.0K	-$1.156M
Cash From Investing Activities
Cash From Financing Activities	$652.0K	$1.064M
Net Change In Cash	-$337.0K	-$92.00K
YoY Change	266.3%	-89.95%
FREE CASH FLOW
Cash From Operating Activities	-$989.0K	-$1.156M
Capital Expenditures
Free Cash Flow		-$1.156M
YoY Change		37.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	POLA	Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities		usd
CY2024Q1	POLA	Line Of Credit Borrowing Capacity LineOfCreditBorrowingCapacity		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-37960
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	POLAR POWER, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0479020
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	249 E. Gardena Blvd.
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Gardena
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90248
CY2024Q1	dei	City Area Code CityAreaCode	(310)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	830-9153
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	POLA
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17561612	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	212000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	549000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1282000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1676000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	16221000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	16522000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	444000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	455000	usd
CY2024Q1	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2023Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2024Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	20946000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	21989000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2530000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2818000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	278000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344000	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	108000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	108000	usd
CY2024Q1	us-gaap	Assets Assets	23862000	usd
CY2023Q4	us-gaap	Assets Assets	25259000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1194000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1762000	usd
CY2024Q1	us-gaap	Deposits Deposits	2545000	usd
CY2023Q4	us-gaap	Deposits Deposits	1618000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1131000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1151000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4914000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4238000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1197000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1124000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11278000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10214000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1537000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1856000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	12815000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12070000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17579089	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17561612	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38886000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38886000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27801000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25659000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17477	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11047000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13189000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23862000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25259000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1775000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2177000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3435000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-402000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	755000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	231000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	333000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	220000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	346000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1126000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1111000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1577000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1790000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1979000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-337000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-92000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	549000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	211000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	212000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	119000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1035000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	163000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	78000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-163000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-78000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2142000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17561612	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17561612	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12949550	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12949550	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13189000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11047000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	17068000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	17068000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2142000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	66000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	116000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-394000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	986000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-301000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1415000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-11000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-777000	usd
CY2024Q1	POLA	Increase Decrease In Amortization Right Of Use Asset IncreaseDecreaseInAmortizationRightOfUseAsset	-288000	usd
CY2023Q1	POLA	Increase Decrease In Amortization Right Of Use Asset IncreaseDecreaseInAmortizationRightOfUseAsset	-196000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-568000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	794000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	927000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	643000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-20000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	25000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-246000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-193000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-989000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1156000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	676000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1127000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	24000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	63000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	652000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1064000	usd
CY2023Q1	POLA	Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities	2392000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-989000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	212000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11047000	usd
CY2024Q1	POLA	Working Capital WorkingCapital	9668000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zZP4OALmKNpi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Material estimates relate to the assumptions made in determining estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term assets, the realizability of deferred tax assets and the related valuation allowance, accruals for warranty reserves, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity. </span>Actual results may differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1775000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1775000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1775000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	14205000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14313000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2016000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2209000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	16221000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	16522000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	71000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	469000	usd
CY2024Q1	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	71000	usd
CY2023	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	469000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zvCu0kqpvBLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentrations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues. </i>For the three months ended March 31, 2024, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zB0v9y4Q4aCk" title="Concentration risk">49</span>% of revenues was generated from the Company’s largest customer (a Tier-1 telecommunications wireless carrier in the U.S), and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9ZXDQdPmmHc" title="Concentration risk">25</span>% of revenue was generated from the Company’s second largest customer ( a customer in the U.S. military market). For the three months ended March 31, 2023, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbnH1L43xAOg" title="Concentration risk">49</span>% of revenues was generated from the Company’s largest customer, a Tier-1 telecommunications customer in the U.S., and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zL3xwnya0wNi" title="Concentration risk">27</span>% of the revenue was generated from a telecommunications customer in the South Pacific. There was no other revenue from customers in excess of 10% of revenues in either period. For the three months ended March 31, 2024 and March 31, 2023, sales to telecommunications customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zyH6JKtlcICk" title="Concentration risk">71</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_z3oZ6RMP5hx7" title="Concentration risk">95</span>% of total revenues, respectively. For the three months ended March 31, 2024 and March 31, 2023, sales to international customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--ProductOrServiceAxis__custom--SalesToInternationalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_ziPObZX426jl" title="Concentration risk">6</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--ProductOrServiceAxis__custom--SalesToInternationalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zn9nEYVfL8Wg" title="Concentration risk">27</span>%, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable</i>. At March 31, 2024, the two largest receivable accounts represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--LargestReceivableAccountsOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zqLfCVYtATdi" title="Concentration risk">70</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--LargestReceivableAccountsTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zLs7j4xT6XNk" title="Concentration risk">10</span>% of the Company’s accounts receivable. <span style="background-color: white">At December 31, 2023, </span>the Company’s two largest receivable accounts represented <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestReceivableAccountsOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0fQUqaJYwl6" title="Concentration risk">69</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestReceivableAccountsTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZY8WhdSCfkc" title="Concentration risk">16</span>% of the Company’s total accounts receivable. There was no other customer that accounted for more than 10% of the Company’s accounts receivable as of March 31, 2024 or December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable</i>. At March 31, 2024, accounts payable to the Company’s three largest vendors represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zKwQxSncZaui" title="Concentration risk">37</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4tctQ37s9Sf" title="Concentration risk">9</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zDsLXQXTOc74" title="Concentration risk">5</span>%, respectively, of the Company’s accounts payable. On December 31, 2023, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z1PuI7CZp4R4" title="Concentration risk">30</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zSY7TD1Wg8ac" title="Concentration risk">10</span>%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zf1mJQEi2h9g" title="Concentration risk">5</span>%, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	140000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164122	shares
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4494000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4494000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4216000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4150000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	278000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	66000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	116000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	63000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	113000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	282000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	212000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	282000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	212000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0613	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0613	pure
CY2024Q1	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	1046000	usd
CY2023Q4	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	760000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2530000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2818000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1197000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1124000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1537000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1856000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2734000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2980000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	968000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1446000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	496000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2910000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	176000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2734000	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	399000	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	287000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	140000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.22
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	140000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	140000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24122	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	12062	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2024Q1	POLA	Employee Retention Credits Wages Percentage EmployeeRetentionCreditsWagesPercentage	0.70	pure
CY2024Q1	POLA	Employee Retention Credits Per Shares EmployeeRetentionCreditsPerShares	7
CY2024Q1	POLA	Expenses Of Employee Retention Credit ExpensesOfEmployeeRetentionCredit	2000000	usd
CY2024Q1	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2023Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd

Files In Submission

Name	View Source	Status
0001493152-24-019861-index-headers.html	Edgar Link	pending
0001493152-24-019861-index.html	Edgar Link	pending
0001493152-24-019861.txt	Edgar Link	pending
0001493152-24-019861-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pola-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pola-20240331_cal.xml	Edgar Link	unprocessable
pola-20240331_def.xml	Edgar Link	unprocessable
pola-20240331_lab.xml	Edgar Link	unprocessable
pola-20240331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POLA
Polar Power, Inc. Stock $pola

2024 Q1 Form 10-Q Financial Statement

#000149315224019861 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA Polar Power, Inc. Stock $pola

2024 Q1 Form 10-Q Financial Statement

#000149315224019861 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA
Polar Power, Inc. Stock $pola